Skip to main content
Clinical Trials/ITMCTR2000004191
ITMCTR2000004191
Recruiting
未知

A randomized controlled clinical study on the effect of moxibustion on the quality of life in patients with gastric cancer

Hebei University of Chinese Meidicne0 sitesTBD
Conditionsgastric cancer

Overview

Phase
未知
Intervention
Not specified
Conditions
gastric cancer
Sponsor
Hebei University of Chinese Meidicne
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Hebei University of Chinese Meidicne

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients who meet the Chinese Society of Clinical Oncology (CSCO) Guidelines for Diagnosis and Treatment of Gastric Cancer (2018\.V1\) diagnosed as gastric cancer by cytology or histopathology;
  • 2\.According to the American Joint Committee on Cancer (AJCC) / The Union for International Cancer Control (UICC) gastric cancer TNM staging system (8th edition), patients who with gastric cancer in stage II, III and IV;
  • 3\.Patients whose inspection indicators are in line with chemotherapy indications and undergoing in chemotherapy treatment;
  • 4\.The patients age from 18 to 70 years old, regardless of gender;
  • 5\.KPS score is over 60;
  • 6\.The estimated survival time is not less than 3 months through symptoms, signs and other auxiliary examinations;
  • 7\.The patients have good compliance, understand the real situation of this study, participate voluntarily, and sign the informed consent.

Exclusion Criteria

  • 1\.Patients in perioperative preoperative chemotherapy
  • 2\.Pregnant or lactating women;
  • 3\..Patients with severe hepatic and renal dysfunction,or combined with severe cardiovascular and cerebrovascular diseases, diabetes, infectious diseases, etc., with obvious bleeding tendency;
  • 4\.Patients with poor compliance, or mental disorders cannot cooperate with treatment;
  • 5\.Patients have been accepted other therapeutic measures similar to this study, which may interfere with or affect the observation indicators of this trial.

Outcomes

Primary Outcomes

Not specified

Similar Trials